{"DataElement":{"publicId":"3838571","version":"2","preferredName":"Solid Tumor Classification Type","preferredDefinition":"A description of the solid tumor classification.","longName":"3838553v1.00:3838555v1.10","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3838553","version":"1","preferredName":"Solid Tumor Classification","preferredDefinition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"3838551v1.0:2321361v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3838551","version":"1","preferredName":"Solid Neoplasm","preferredDefinition":"Cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"C9292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FC56-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"ONEDATA","dateModified":"2013-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FC64-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3838555","version":"1.1","preferredName":"Solid Tumor Type","preferredDefinition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors._Something distinguishable as an identifiable class based on common qualities.","longName":"3838555v1.10","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Breast cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581329","version":"1","preferredName":"Breast Carcinoma","longName":"5581329","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30F8-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Tumors of the head / neck","valueDescription":null,"ValueMeaning":{"publicId":"2593169","version":"1","preferredName":"Head and Neck Neoplasm","longName":"2593169","preferredDefinition":"A benign or malignant neoplasm affecting one of the following areas: base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Neoplasm","conceptCode":"C3077","definition":"A benign or malignant neoplasm that affects the anatomic structures of the head and neck region.  Representative examples of benign neoplasms include salivary gland pleomorphic adenoma and nasal cavity papilloma.  Representative examples of malignant neoplasms include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28701A35-6596-579B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30F9-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Colorectal","valueDescription":null,"ValueMeaning":{"publicId":"4722734","version":"1","preferredName":"Colorectal Carcinoma","longName":"4722734","preferredDefinition":"A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Carcinoma","conceptCode":"C2955","definition":"A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1E70-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30FA-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Pancreatic","valueDescription":null,"ValueMeaning":{"publicId":"5581339","version":"1","preferredName":"Pancreatic Carcinoma","longName":"5581339","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B839-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30FB-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Tumors of the stomach","valueDescription":null,"ValueMeaning":{"publicId":"2593172","version":"1","preferredName":"Gastric Neoplasm","longName":"2593172","preferredDefinition":"Cancerous or non-cancerous tumors of the stomach","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neoplasm","conceptCode":"C3387","definition":"A benign or malignant neoplasm involving the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28701A35-65CB-579B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30FD-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Atypical teratoid rhabdoid tumor (ATRT)","valueDescription":null,"ValueMeaning":{"publicId":"4722554","version":"1","preferredName":"Atypical Teratoid/Rhabdoid Tumor","longName":"4722554","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system.  It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  It may be associated with loss of chromosome 22.  The vast majority of cases occur in childhood.  Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B6B7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30FE-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Central nervous system tumor, including CNS PNET","valueDescription":null,"ValueMeaning":{"publicId":"2672911","version":"1","preferredName":"Central Nervous System Carcinoma","longName":"2672911","preferredDefinition":"A malignant tumor arising in the epithelial cells of the brain or spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Carcinoma","conceptCode":"C62332","definition":"A malignant tumor arising in the epithelial cells of the brain or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A754-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-30FF-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Diffuse intrinsic pontine glioma (DIPG)","valueDescription":null,"ValueMeaning":{"publicId":"10497047","version":"1","preferredName":"Diffuse Intrinsic Pontine Glioma","longName":"10497047v1.00","preferredDefinition":"A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Intrinsic Pontine Glioma","conceptCode":"C94764","definition":"A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9392-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3100-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Ependymoma","valueDescription":null,"ValueMeaning":{"publicId":"2578706","version":"1","preferredName":"Ependymoma","longName":"2578706","preferredDefinition":"Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3101-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Glioblastoma multiforme (GBM)","valueDescription":null,"ValueMeaning":{"publicId":"3686274","version":"1","preferredName":"Glioblastoma","longName":"3686274","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FFB-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3102-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Medulloblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4265264","version":"1","preferredName":"Medulloblastoma","longName":"4265264","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, large cell medulloblastoma, and medulloblastoma with extensive nodularity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4D75-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3103-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Bone sarcoma (excluding Ewing family tumors)","valueDescription":null,"ValueMeaning":{"publicId":"2593148","version":"1","preferredName":"Bone Sarcoma","longName":"2593148","preferredDefinition":"A malignant mesenchymal tumor of the bone.  Bone sarcomas can either arise from the bones (primary bone sarcomas) or spread to the bones from other anatomic sites. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Sarcoma","conceptCode":"C9312","definition":"A sarcoma that arises from the bone.  Representative examples are osteosarcoma and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E67-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3104-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Desmoplastic small round cell tumors","valueDescription":null,"ValueMeaning":{"publicId":"3179342","version":"1","preferredName":"Desmoplastic Small Round Cell Tumor","longName":"3179342","preferredDefinition":"An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Small Round Cell Tumor","conceptCode":"C8300","definition":"An aggressive malignant soft tissue neoplasm of uncertain differentiation.  It is characterized by a recurrent chromosomal translocation t(11;22)(p13;q12) and the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8341-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3105-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Ewing family tumors of bone (including PNET)","valueDescription":null,"ValueMeaning":{"publicId":"2672907","version":"1","preferredName":"Ewing Sarcoma of Bone","longName":"2672907","preferredDefinition":"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation.  It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor.  It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones.  Clinical findings include pain and a mass in the involved area.  Fever, anemia, leucocytosis, and an increased sedimentation rate are often seen.  X-ray examination reveals osteolytic lesions.  The prognosis depends on the stage, anatomic location, and size of the tumor. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ewing Sarcoma of Bone","conceptCode":"C4835","definition":"A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation.  It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor.  It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones.  Clinical findings include pain and a mass in the involved area.  Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen.  X-ray examination reveals osteolytic lesions.  The prognosis depends on the stage, anatomic location, and size of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A6E0-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3106-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Ewing family tumors, extraosseous (including PNET)","valueDescription":null,"ValueMeaning":{"publicId":"2672909","version":"1","preferredName":"Extraosseous Ewing Sarcoma","longName":"2672909","preferredDefinition":"This is a rare malignant neoplasm of the soft tissue.  It is typically a disease of children and young adults.  It is characterized by t(11:22) (q24: q12) resulting in the expression of EWS/FLI-1 chimeric transcript.  Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities.  Treatment includes local excision with consideration for post operative chemotherapy and/or radiotherapy. - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extraskeletal Ewing Sarcoma","conceptCode":"C7135","definition":"A rare malignant neoplasm of the soft tissues. It is typically a disease of children and young adults. Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities. Treatment includes local excision with consideration for post-operative chemotherapy and/or radiotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A708-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3107-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Malignant Peripheral Nerve Sheath Tumor","valueDescription":null,"ValueMeaning":{"publicId":"2838605","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor","longName":"2838605","preferredDefinition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C3798","definition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE88-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3108-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Myxoid round cell sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4264959","version":"1","preferredName":"Myxoid/Round Cell Liposarcoma","longName":"4264959","preferredDefinition":"A liposarcoma characterized by the presence of round non-lipogenic mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a vascular-branching pattern, or the presence of solid sheets of primitive round cells without myxoid stroma. The tumor is usually well-circumscribed. The majority of cases arise from within the thigh muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoid Liposarcoma","conceptCode":"C27781","definition":"A liposarcoma characterized by the presence of round non-lipogenic primitive mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a branching vascular pattern.  This category includes hypercellular lesions with round cell morphology, formerly known as round cell liposarcoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3ADA-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3109-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4265253","version":"1","preferredName":"Rhabdomyosarcoma","longName":"4265253","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyosarcoma","conceptCode":"C3359","definition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BB4-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310A-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Synovial sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3251907","version":"1","preferredName":"Synovial Sarcoma","longName":"3251907","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A77CE4DC-22FC-EFB7-E040-BB89AD430FFC","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"MAESKEB","dateModified":"2018-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310B-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other soft tissue sarcoma (excluding Ewing family tumors)","valueDescription":null,"ValueMeaning":{"publicId":"3384698","version":"1","preferredName":"Soft Tissue Sarcoma","longName":"3384698","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A3DDB0-75C8-1600-E040-BB89AD432CFF","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310C-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Germ cell tumors, gonadal","valueDescription":null,"ValueMeaning":{"publicId":"14679107","version":"1","preferredName":"Childhood Gonadal Germ Cell Tumor","longName":"14679107v1.00","preferredDefinition":"A germ cell tumor that arises from the testis or ovary and occurs during childhood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Gonadal Germ Cell Tumor","conceptCode":"C114801","definition":"A germ cell tumor that arises from the testis or ovary and occurs during childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F25F434-30F7-71F4-E063-731AD00AF152","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310D-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Germ cell tumor, extragonadal","valueDescription":null,"ValueMeaning":{"publicId":"3322765","version":"1","preferredName":"Extragonadal Germ Cell Tumor","longName":"3322765","preferredDefinition":"A germ cell tumor arising in an anatomic site other than the testis or ovary (e.g., central nervous system, lung, mediastinum, and retroperitoneum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extragonadal Germ Cell Tumor","conceptCode":"C3918","definition":"A germ cell tumor arising in an anatomic site other than the testis or ovary (e.g., central nervous system, lung, mediastinum, and retroperitoneum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3714D57-A897-7A8F-E040-BB89AD43536C","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310E-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Neuroblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4265259","version":"1","preferredName":"Neuroblastoma","longName":"4265259","preferredDefinition":"A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4CCE-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-310F-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Mediastinal neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"2593231","version":"1","preferredName":"Mediastinal Neoplasm","longName":"2593231","preferredDefinition":"A benign or malignant, primary or metastatic neoplasm affecting the mediastinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mediastinal Neoplasm","conceptCode":"C3221","definition":"A benign or malignant neoplasm that affects the structures of the mediastinum.  Representative examples include mediastinal lipoma, mediastinal schwannoma, thymoma, mediastinal germ cell tumor, and mediastinal lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2870B392-3B41-4CD9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3110-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Tumors of the lung (include adenocarcinoma, Squamous carcinoma, small cell, large cell)","valueDescription":null,"ValueMeaning":{"publicId":"2673720","version":"1","preferredName":"Lung Neoplasm","longName":"2673720","preferredDefinition":"Abnormal growth in a lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Neoplasm","conceptCode":"C3200","definition":"A benign or malignant, primary or metastatic neoplasm involving the lungs.  Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma.  Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3822126C-B074-1192-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3111-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Tumor of the pleura (Mesothelioma)","valueDescription":null,"ValueMeaning":{"publicId":"6156323","version":"1","preferredName":"Mesothelial Neoplasm","longName":"6156323","preferredDefinition":"A benign or malignant neoplasm arising from mesothelial cells.  Mesothelial cells are the lining cells of the pleura and peritoneum. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelial Neoplasm","conceptCode":"C3786","definition":"A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EE87-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3112-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":null,"ValueMeaning":{"publicId":"5581342","version":"1","preferredName":"Melanoma","longName":"5581342","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3113-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Ovarian (epithelial)","valueDescription":null,"ValueMeaning":{"publicId":"2593147","version":"1","preferredName":"Ovarian Carcinoma","longName":"2593147","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E43-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3114-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Prostate","valueDescription":null,"ValueMeaning":{"publicId":"5581340","version":"1","preferredName":"Prostate Carcinoma","longName":"5581340","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B85C-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3115-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Renal cell","valueDescription":null,"ValueMeaning":{"publicId":"3248535","version":"1","preferredName":"Renal Cell Carcinoma","longName":"3248535","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BA15-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3116-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Vaginal","valueDescription":null,"ValueMeaning":{"publicId":"2593186","version":"1","preferredName":"Vaginal Neoplasm","longName":"2593186","preferredDefinition":"Tumors or cancer of the VAGINA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Neoplasm","conceptCode":"C3437","definition":"A benign or malignant neoplasm affecting the vagina. Representative examples of benign neoplasms include squamous papilloma and melanocytic nevus. Representative examples of malignant neoplasms include carcinoma, melanoma, and sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28701A35-669F-579B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3117-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Malignant Rhabdoid Tumor of the Kidney","valueDescription":null,"ValueMeaning":{"publicId":"3210727","version":"1","preferredName":"Rhabdoid Tumor of the Kidney","longName":"3210727","preferredDefinition":"A rhabdoid tumor that arises from the kidney.  It occurs in children and it is associated with abnormalities of chromosome 22. It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdoid Tumor of the Kidney","conceptCode":"C8715","definition":"A rhabdoid tumor that arises from the kidney.  It occurs in children and it is associated with abnormalities of chromosome 22. It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9526-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3118-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Retinoblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4265254","version":"1","preferredName":"Retinoblastoma","longName":"4265254","preferredDefinition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinoblastoma","conceptCode":"C7541","definition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BEC-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-3119-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Wilms tumor","valueDescription":null,"ValueMeaning":{"publicId":"2593188","version":"1","preferredName":"Wilms Tumor","longName":"2593188","preferredDefinition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wilms Tumor","conceptCode":"C3267","definition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28701A35-66BA-579B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-311A-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Solid tumor, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"5438011","version":"1","preferredName":"Solid Neoplasm","longName":"5438011","preferredDefinition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-6791-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-311B-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other solid tumor","valueDescription":null,"ValueMeaning":{"publicId":"2672902","version":"1","preferredName":"Other Solid Neoplasm","longName":"2672902","preferredDefinition":"Not otherwise specified.: Cancer of body tissues other than blood, bone marrow, or the lymphatic system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A576-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F25F434-311C-71F4-E063-731AD00AF152","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Tumors of liver and intrahepatic bile ducts","valueDescription":null,"ValueMeaning":{"publicId":"5581335","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Carcinoma","longName":"5581335","preferredDefinition":"Primary liver cancer is cancer that forms in the tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Carcinoma","conceptCode":"C7927","definition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FB4802C-7CC6-41D7-E063-731AD00ACA46","beginDate":"2024-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-24","modifiedBy":"KUMMEROA","dateModified":"2024-01-24","deletedIndicator":"No"},{"value":"Tumor of the esophagus and gastro-esophageal (GE) junction","valueDescription":null,"ValueMeaning":{"publicId":"14727026","version":"1","preferredName":"Esophageal and Gastroesophageal Junction Carcinoma","longName":"14727026v1.00","preferredDefinition":"A carcinoma that arises from the esophagus or gastroesophageal junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal and Gastroesophageal Junction Carcinoma","conceptCode":"C203673","definition":"A carcinoma that arises from the esophagus or gastroesophageal junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FB56578-1DBD-78BF-E063-731AD00A70A3","latestVersionIndicator":"Yes","beginDate":"2024-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-24","modifiedBy":"KUMMEROA","dateModified":"2024-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FB56578-1DBE-78BF-E063-731AD00A70A3","beginDate":"2024-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-24","modifiedBy":"KUMMEROA","dateModified":"2024-01-24","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F7F3E-9CA7-6A90-E063-731AD00A8461","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"},{"value":"Lung, non-small cell","valueDescription":null,"ValueMeaning":{"publicId":"3534668","version":"1","preferredName":"NSCLC","longName":"3534668","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C597D472-1BE4-C3F6-E040-BB89AD434BBD","latestVersionIndicator":"Yes","beginDate":"2012-07-24","endDate":null,"createdBy":"LEL","dateCreated":"2012-07-24","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F7F3E-9CA8-6A90-E063-731AD00A8461","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"},{"value":"Lung, small cell","valueDescription":null,"ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F7F3E-9CA9-6A90-E063-731AD00A8461","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"},{"value":"Lung, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"5581336","version":"1","preferredName":"Lung Carcinoma","longName":"5581336","preferredDefinition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F7F3E-9CAA-6A90-E063-731AD00A8461","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"},{"value":"Squamous carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4264988","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"4264988","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3EBF-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F7F3E-9CAB-6A90-E063-731AD00A8461","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"},{"value":"Testicular","valueDescription":null,"ValueMeaning":{"publicId":"2672904","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor","longName":"2672904","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Germ Cell Tumor","conceptCode":"C9063","definition":"A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A5B6-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"102F8EE1-B1AF-6D61-E063-731AD00A49DB","beginDate":"2024-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-30","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3838554","version":"1","preferredName":"Solid Neoplasm Type","preferredDefinition":"Cancer of body tissues other than blood, bone marrow, or the lymphatic system.:Something distinguishable as an identifiable class based on common qualities.","longName":"C9292:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FC7A-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"ONEDATA","dateModified":"2013-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"0F25CB70-5349-6A56-E063-731AD00AB61B","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","changeDescription":". Added PV for 4000. AK 3/15/17","administrativeNotes":"2024.1.30 Added PVs per ticket request CADSR0003343. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set  Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_prime_dis_hct_solid_tumor_class","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_ICT_solid_tumor_cl","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_ST_solid_tumor_class","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the solid tumor classification?","url":null,"context":"NHLBI"},{"name":"Specify the solid tumor classification","type":"Application Standard Question Text","description":"Specify the solid tumor classification","url":null,"context":"NHLBI"},{"name":"Specify the solid tumor classification","type":"Alternate Question Text","description":"Specify the solid tumor classification","url":null,"context":"NHLBI"},{"name":"Specify solid tumor classification","type":"Alternate Question Text","description":"Specify solid tumor classification","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"0F261473-CEFF-79BB-E063-731AD00A1A13","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":". Added human readable def. System generated def displayed as alt def. No version needed. AK 11/17/14. 2/4/16mn-added aqt for 4000; Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":"2024.1.17 Created per ticket request CADSR0003263. ak","unresolvedIssues":null,"deletedIndicator":"No"}}